《本地樓市》嘉華(00173.HK)5.51億元奪醫院道地皮 樓面呎價1.28萬元低預期
地政總署公布,嘉華國際(00173.HK)以5.51億元,投得位於香港醫院道的內地段第8872號的用地,批租期為50年。每方呎樓面地價12,821元,低於市場預期下限。
該地上星期五(22日)截標,一共收到11份標書,有份入標的包括會德豐地產、信和置業(00083.HK)、恆地(00012.HK)、英皇國際(00163.HK)、長實(01113.HK)、漢國置業(00160.HK)等。
該幅醫院道地皮面積約5,372方呎,指定作私人住宅用途。估計可建樓面面積約42,978方呎,地皮估值約5.8億至8.51億元,樓面呎價約1.35萬至1.98萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.